David Pendarvis - Jun 30, 2023 Form 4 Insider Report for RESMED INC (RMD)

Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
6/30/2023, 12:28 PM
Previous filing
Jun 7, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 89.7K Jun 30, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David Pendarvis is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Reporting Person no longer an executive officer effective June 30, 2023.